TherapeuticsMD, Inc. (TXMD): Price and Financial Metrics


TherapeuticsMD, Inc. (TXMD)

Today's Latest Price: $1.22 USD

0.10 (-7.58%)

Updated Oct 30 4:00pm

Add TXMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

TXMD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for TXMD is -0.67 -- better than only 5.7% of US stocks.
  • TXMD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 2.56% of US stocks.
  • Revenue growth over the past 12 months for TherapeuticsMD Inc comes in at 236.62%, a number that bests 97.16% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to TXMD, based on their financial statements, market capitalization, and price volatility, are CVV, KIDS, XTNT, WING, and MSON.
  • TXMD's SEC filings can be seen here. And to visit TherapeuticsMD Inc's official web site, go to www.therapeuticsmd.com.

TXMD Stock Price Chart Interactive Chart >

Price chart for TXMD

TXMD Price/Volume Stats

Current price $1.22 52-week high $2.96
Prev. close $1.32 52-week low $0.85
Day low $1.20 Volume 3,954,600
Day high $1.34 Avg. volume 4,293,393
50-day MA $1.49 Dividend yield N/A
200-day MA $1.53 Market Cap 332.20M

TherapeuticsMD, Inc. (TXMD) Company Bio


TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company was founded in 2008 and is based in Boca Raton, Florida.


TXMD Latest News Stream


Event/Time News Detail
Loading, please wait...

TXMD Latest Social Stream


Loading social stream, please wait...

View Full TXMD Social Stream

Latest TXMD News From Around the Web

Below are the latest news stories about TherapeuticsMD Inc that investors may wish to consider to help them evaluate TXMD as an investment opportunity.

TherapeuticsMD Provides Update on Third Quarter Progress

BOCA RATON, Fla.--(BUSINESS WIRE)--3Q Update PR

Business Wire | September 25, 2020

TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences

BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD to participate in two virtual investor conferences in September

Business Wire | September 10, 2020

TherapeuticsMD Announces Patent Updates for ANNOVERA®

BOCA RATON, Fla.--(BUSINESS WIRE)--TXMD increases patent protection on ANNOVERA

Business Wire | September 9, 2020

TherapeuticsMD: Remaining Bullish On This Reopening Play In The Biotech Sector

TherapeuticsMD (TXMD) has been a blight in my speculative portfolio for nearly two years as the share price continues to deteriorate and investor sentiment hits rock bottom. At first, I was willing to pay a premium and was confident that the company’s impressive product portfolio and commercial progress were going...

Biologics on Seeking Alpha | August 30, 2020

TherapeuticsMD/Knight Therapeutics' Imvexxy OK'd in Canada

Health Canada approves TherapeuticsMD (TXMD) and Knight Therapeutics' (KHTRF) Imvexxy for the treatment of postmenopausal moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy ((VVA)).Imvexxy is an applicator-free, estradiol softgel vaginal capsule indicated for postmenopausal women who experience pain before, during or after intercourse. The companies signed a licensing agreement...

Seeking Alpha | August 25, 2020

Read More 'TXMD' Stories Here

TXMD Price Returns

1-mo -22.78%
3-mo -34.05%
6-mo -11.59%
1-year -54.14%
3-year -74.15%
5-year -79.22%
YTD -49.59%
2019 -36.48%
2018 -36.92%
2017 4.68%
2016 -44.36%
2015 133.03%

Continue Researching TXMD

Here are a few links from around the web to help you further your research on TherapeuticsMD Inc's stock as an investment opportunity:

TherapeuticsMD Inc (TXMD) Stock Price | Nasdaq
TherapeuticsMD Inc (TXMD) Stock Quote, History and News - Yahoo Finance
TherapeuticsMD Inc (TXMD) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8766 seconds.